March 16 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX :
* SEEKS TRADING HALT PENDING RESULTS FROM COMPANY'S PRE-CLINICAL STUDY IN MULTIPLE SCLEROSIS MODEL.
* SEEKS TRADING HAL PENDING RELEASE OF POSITIVE RESULTS FROM CO'S PRE-CLINICAL STUDY IN MULTIPLE SCLEROSIS MODEL